Alector (ALEC) News Today $3.94 +0.18 (+4.79%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Alector’s Strategic Advances in Immuno-NeurologyNovember 22 at 1:49 PM | markets.businessinsider.comAlector Secures Funding to Advance Clinical TrialsNovember 15, 2024 | markets.businessinsider.comAlector Secures Flexible Credit Facility for Up to $50 Million From Hercules CapitalNovember 14, 2024 | globenewswire.comAlector, Inc. (NASDAQ:ALEC) Shares Sold by Baillie Gifford & Co.Baillie Gifford & Co. cut its holdings in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 69.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 78,835 shares of the company's stock after selling 181,November 14, 2024 | marketbeat.comFY2024 Earnings Forecast for Alector Issued By HC WainwrightAlector, Inc. (NASDAQ:ALEC - Free Report) - Equities research analysts at HC Wainwright lifted their FY2024 earnings per share (EPS) estimates for Alector in a report released on Thursday, November 7th. HC Wainwright analyst A. Fein now forecasts that the company will earn ($1.79) per share for tNovember 11, 2024 | marketbeat.comWilliam Blair Has Strong Outlook for Alector FY2024 EarningsAlector, Inc. (NASDAQ:ALEC - Free Report) - Investment analysts at William Blair increased their FY2024 earnings estimates for shares of Alector in a research note issued to investors on Wednesday, November 6th. William Blair analyst M. Minter now anticipates that the company will post earnings pNovember 11, 2024 | marketbeat.comAlector (NASDAQ:ALEC) Releases Quarterly Earnings Results, Beats Estimates By $0.10 EPSAlector (NASDAQ:ALEC - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.43) earnings per share for the quarter, topping analysts' consensus estimates of ($0.53) by $0.10. The firm had revenue of $15.34 million during the quarter, compared to analysts' expectations of $16.33 million. Alector had a negative net margin of 290.66% and a negative return on equity of 102.63%.November 9, 2024 | marketbeat.comStifel Nicolaus Sticks to Its Buy Rating for Alector (ALEC)November 9, 2024 | markets.businessinsider.comPromising Developments in Alector’s Alzheimer’s Treatments Drive Buy RatingNovember 7, 2024 | markets.businessinsider.comAlector’s Promising Phase 2 Study and Strong Financial Outlook Justify Buy RatingNovember 7, 2024 | markets.businessinsider.comAlector (NASDAQ:ALEC) Receives Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $35.00 price target on shares of Alector in a research note on Thursday.November 7, 2024 | marketbeat.comAlector Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 6, 2024 | globenewswire.comAlector (NASDAQ:ALEC) Stock Price Up 7% - Still a Buy?Alector (NASDAQ:ALEC) Trading 7% Higher - Should You Buy?November 4, 2024 | marketbeat.comIs Alector (NASDAQ:ALEC) In A Good Position To Deliver On Growth Plans?October 30, 2024 | finance.yahoo.comCautious Optimism for Alector’s AL002 Amid Promising Alzheimer’s Data and Investor CautionOctober 25, 2024 | markets.businessinsider.comAlector (ALEC) Receives a Buy from BarclaysOctober 19, 2024 | markets.businessinsider.comAlector, Inc. (NASDAQ:ALEC) Short Interest Up 19.9% in SeptemberAlector, Inc. (NASDAQ:ALEC - Get Free Report) was the target of a significant growth in short interest in September. As of September 30th, there was short interest totalling 4,150,000 shares, a growth of 19.9% from the September 15th total of 3,460,000 shares. Based on an average daily volume of 553,000 shares, the short-interest ratio is currently 7.5 days. Currently, 5.5% of the shares of the stock are short sold.October 14, 2024 | marketbeat.comAlector, Inc. (NASDAQ:ALEC) Holdings Trimmed by Marshall Wace LLPMarshall Wace LLP lowered its position in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 70.3% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 52,609 shares of the company's stock after selling 124,October 13, 2024 | marketbeat.comDimensional Fund Advisors LP Sells 169,888 Shares of Alector, Inc. (NASDAQ:ALEC)Dimensional Fund Advisors LP trimmed its holdings in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 20.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 676,076 shares of the company's stock after sellOctober 11, 2024 | marketbeat.comCalluna Pharma appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the BoardOctober 9, 2024 | finance.yahoo.comAlector’s AL002 Holds Potential Amidst Uncertainties: A Hold Rating AnalysisOctober 1, 2024 | markets.businessinsider.comOne in Three Former NFL Players Believe They Have CTESeptember 24, 2024 | msn.comAlector (NASDAQ:ALEC) Shares Down 5.6% Alector (NASDAQ:ALEC) Stock Price Down 5.6%September 23, 2024 | marketbeat.comAlector (NASDAQ:ALEC) investors are sitting on a loss of 77% if they invested three years agoSeptember 19, 2024 | finance.yahoo.comCantor Fitzgerald Reaffirms Overweight Rating for Alector (NASDAQ:ALEC)Cantor Fitzgerald reissued an "overweight" rating on shares of Alector in a research note on Tuesday.September 17, 2024 | marketbeat.comAcadian Asset Management LLC Purchases 146,015 Shares of Alector, Inc. (NASDAQ:ALEC)Acadian Asset Management LLC lifted its position in Alector, Inc. (NASDAQ:ALEC - Free Report) by 32.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 590,662 shares of the company's stocSeptember 14, 2024 | marketbeat.comAlector (NASDAQ:ALEC) Shares Down 4.1% Alector (NASDAQ:ALEC) Shares Down 4.1%September 12, 2024 | marketbeat.comAlector (NASDAQ:ALEC) Trading 3.6% Higher Alector (NASDAQ:ALEC) Trading Up 3.6%September 10, 2024 | marketbeat.comAlector, Inc. (NASDAQ:ALEC) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Alector, Inc. (NASDAQ:ALEC - Get Free Report) have earned an average recommendation of "Moderate Buy" from the six brokerages that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation and five have given a buy recommendation toSeptember 10, 2024 | marketbeat.comAlector's (ALEC) "Overweight" Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating on shares of Alector in a report on Monday.September 9, 2024 | marketbeat.comMarc Grasso Sells 7,297 Shares of Alector, Inc. (NASDAQ:ALEC) StockSeptember 5, 2024 | insidertrades.comAlector, Inc. (NASDAQ:ALEC) CFO Sells $35,609.36 in StockAlector, Inc. (NASDAQ:ALEC - Get Free Report) CFO Marc Grasso sold 7,297 shares of Alector stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $4.88, for a total value of $35,609.36. Following the completion of the sale, the chief financial officer now owns 130,740 shares of the company's stock, valued at approximately $638,011.20. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.September 4, 2024 | marketbeat.comAlector, Inc. (NASDAQ:ALEC) Sees Large Decrease in Short InterestAlector, Inc. (NASDAQ:ALEC - Get Free Report) saw a significant drop in short interest in August. As of August 15th, there was short interest totalling 3,680,000 shares, a drop of 10.2% from the July 31st total of 4,100,000 shares. Approximately 4.9% of the company's shares are short sold. Based on an average daily volume of 638,000 shares, the days-to-cover ratio is presently 5.8 days.September 1, 2024 | marketbeat.comAlector, Inc. (NASDAQ:ALEC) Shares Acquired by Panagora Asset Management Inc.Panagora Asset Management Inc. lifted its stake in Alector, Inc. (NASDAQ:ALEC - Free Report) by 61.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 355,318 shares of the company's stock after buying an additionalSeptember 1, 2024 | marketbeat.comAlector to Participate in Upcoming Healthcare ConferencesAugust 29, 2024 | globenewswire.comBaillie Gifford & Co. Cuts Stock Position in Alector, Inc. (NASDAQ:ALEC)Baillie Gifford & Co. trimmed its holdings in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 19.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 260,442 shares of the company's stock after selling 62,387August 26, 2024 | marketbeat.comAlector (NASDAQ:ALEC) Trading 8.6% Higher Alector (NASDAQ:ALEC) Trading 8.6% HigherAugust 15, 2024 | marketbeat.comPaula Hammond Sells 10,500 Shares of Alector, Inc. (NASDAQ:ALEC) StockAugust 14, 2024 | insidertrades.comInsider Selling: Alector, Inc. (NASDAQ:ALEC) Director Sells 10,500 Shares of StockAlector, Inc. (NASDAQ:ALEC - Get Free Report) Director Paula Hammond sold 10,500 shares of the stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $5.06, for a total value of $53,130.00. Following the completion of the sale, the director now directly owns 60,209 shares in the company, valued at approximately $304,657.54. The transaction was disclosed in a document filed with the SEC, which is available through this link.August 13, 2024 | marketbeat.comAlector’s Strong Outlook: Advancing Pipeline and Undervalued Stock Prompt Buy RatingAugust 13, 2024 | markets.businessinsider.comAlector, Inc. (NASDAQ:ALEC) to Post Q3 2024 Earnings of ($0.58) Per Share, HC Wainwright ForecastsAlector, Inc. (NASDAQ:ALEC - Free Report) - Stock analysts at HC Wainwright dropped their Q3 2024 EPS estimates for Alector in a note issued to investors on Thursday, August 8th. HC Wainwright analyst A. Fein now forecasts that the company will earn ($0.58) per share for the quarter, down from thAugust 12, 2024 | marketbeat.comVanguard Group Inc. Acquires 526,037 Shares of Alector, Inc. (NASDAQ:ALEC)Vanguard Group Inc. grew its stake in Alector, Inc. (NASDAQ:ALEC - Free Report) by 12.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,912,578 shares of the company's stock after purchasiAugust 10, 2024 | marketbeat.comAlector, Inc. (ALEC) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comAlector Second Quarter 2024 Earnings: Beats ExpectationsAugust 9, 2024 | finance.yahoo.comResearch Analysts Issue Forecasts for Alector, Inc.'s Q1 2025 Earnings (NASDAQ:ALEC)Alector, Inc. (NASDAQ:ALEC - Free Report) - William Blair issued their Q1 2025 earnings estimates for Alector in a report issued on Thursday, August 8th. William Blair analyst M. Minter forecasts that the company will post earnings of ($0.47) per share for the quarter. The consensus estimate forAugust 9, 2024 | marketbeat.comAlector (NASDAQ:ALEC) Issues Quarterly Earnings Results, Beats Expectations By $0.09 EPSAlector (NASDAQ:ALEC - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.40) earnings per share for the quarter, beating analysts' consensus estimates of ($0.49) by $0.09. The firm had revenue of $15.08 million for the quarter, compared to analyst estimates of $16.04 million. Alector had a negative net margin of 125.11% and a negative return on equity of 71.80%. During the same quarter in the previous year, the firm posted $0.02 earnings per share.August 8, 2024 | marketbeat.comAnalyst Issues Buy Rating on Alector Amid Promising Biomarker Research and Positive FDA InteractionsAugust 8, 2024 | markets.businessinsider.comAlector Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 7, 2024 | finance.yahoo.comABBV Aug 2024 162.500 call (ABBV240809C00162500)August 5, 2024 | finance.yahoo.comPrice T Rowe Associates Inc. MD Sells 311,055 Shares of Alector, Inc. (NASDAQ:ALEC)Price T Rowe Associates Inc. MD decreased its stake in Alector, Inc. (NASDAQ:ALEC - Free Report) by 25.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 890,494 shares of the company's stock after sellingAugust 5, 2024 | marketbeat.com Get Alector News Delivered to You Automatically Sign up to receive the latest news and ratings for ALEC and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. ALEC Media Mentions By Week ALEC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALEC News Sentiment▼0.000.49▲Average Medical News Sentiment ALEC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALEC Articles This Week▼12▲ALEC Articles Average Week Get Alector News Delivered to You Automatically Sign up to receive the latest news and ratings for ALEC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies iTeos Therapeutics News C4 Therapeutics News REGENXBIO News Inhibrx News Black Diamond Therapeutics News Compugen News Travere Therapeutics News Intellia Therapeutics News Spyre Therapeutics News Praxis Precision Medicines News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALEC) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredReality Check: Are You Prepared for What's Next?Global shifts, like the alliance of BRICS nations pushing for economic independence from the U.S. dollar, and ...Allegiance Gold | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alector, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alector With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
